[go: up one dir, main page]

IS3813A - Mótefni gegn viðtökum fyrir IgE og aðferð til framleiðslu þess - Google Patents

Mótefni gegn viðtökum fyrir IgE og aðferð til framleiðslu þess

Info

Publication number
IS3813A
IS3813A IS3813A IS3813A IS3813A IS 3813 A IS3813 A IS 3813A IS 3813 A IS3813 A IS 3813A IS 3813 A IS3813 A IS 3813A IS 3813 A IS3813 A IS 3813A
Authority
IS
Iceland
Prior art keywords
antibody
production
ige receptor
ige
receptor
Prior art date
Application number
IS3813A
Other languages
English (en)
Inventor
Anthony Chizzonite Richard
Hakimi John
Peter Kochan Jarema
Original Assignee
F.Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F.Hoffmann-La Roche Ag filed Critical F.Hoffmann-La Roche Ag
Publication of IS3813A publication Critical patent/IS3813A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against Fc-receptors, e.g. CD16, CD32, CD64
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IS3813A 1991-02-11 1992-02-10 Mótefni gegn viðtökum fyrir IgE og aðferð til framleiðslu þess IS3813A (is)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65393691A 1991-02-11 1991-02-11

Publications (1)

Publication Number Publication Date
IS3813A true IS3813A (is) 1992-08-12

Family

ID=24622869

Family Applications (1)

Application Number Title Priority Date Filing Date
IS3813A IS3813A (is) 1991-02-11 1992-02-10 Mótefni gegn viðtökum fyrir IgE og aðferð til framleiðslu þess

Country Status (20)

Country Link
EP (1) EP0499112A1 (is)
JP (1) JPH05252988A (is)
KR (1) KR920016105A (is)
AR (1) AR245784A1 (is)
AU (1) AU652024B2 (is)
BR (1) BR9200442A (is)
CA (1) CA2059842A1 (is)
CS (1) CS39092A3 (is)
FI (1) FI920565L (is)
HU (1) HUT63205A (is)
IE (1) IE920434A1 (is)
IL (1) IL100869A0 (is)
IS (1) IS3813A (is)
MX (1) MX9200526A (is)
NO (1) NO920523L (is)
NZ (1) NZ241552A (is)
RO (1) RO109707B1 (is)
UY (1) UY23374A1 (is)
YU (1) YU13392A (is)
ZA (1) ZA92800B (is)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770396A (en) * 1992-04-16 1998-06-23 The United States Of America As Represented By The Department Of Health And Human Services Isolation characterization, and use of the human beta subunit of the high affinity receptor for immunoglobulin E
DK0733207T3 (da) * 1993-12-10 1998-04-20 Genentech Inc Fremgangsmåder til diagnose af allergi og screening af anti-allergi-terapeutika
JP2952750B2 (ja) * 1995-02-23 1999-09-27 株式会社林原生物化学研究所 モノクローナル抗体
US7135458B1 (en) 1995-11-15 2006-11-14 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Interferon-γ inducing polypeptide, pharmaceutical composition thereof, monoclonal antibody thereto, and methods of use
PE99498A1 (es) * 1996-07-26 1999-01-21 Novartis Ag Polipeptidos de fusion
US6423512B1 (en) 1996-07-26 2002-07-23 Novartis Ag Fusion polypeptides
US6299875B1 (en) * 1998-06-04 2001-10-09 Panacea Pharmaceuticals, Llc Methods to block IGE binding to cell surface receptors of mast cells
US7759133B2 (en) * 1998-12-22 2010-07-20 Alk-Abello A/S Method of detecting and/or quantifying a specific IgE antibody in a liquid sample
EP1269198A2 (en) * 2000-03-23 2003-01-02 Novartis AG Identification of mast/basophil activation inhibitors
KR100932465B1 (ko) 2001-07-19 2009-12-17 자이단호진 가가쿠오요비겟세이료호겐쿠쇼 인간형 항인간 ＩｇＥ 수용체 항체 및 항체 단편
CA2676843A1 (en) * 2007-01-29 2008-08-07 Valtion Teknillinen Tutkimuskeskus Method for producing novel ige based reagents
KR101686395B1 (ko) 2015-06-22 2016-12-15 주식회사 선일기연 Ｐｃｂ용 단자 삽입기의 삽입력 측정장치
CN105352930A (zh) * 2015-12-01 2016-02-24 深圳市绿诗源生物技术有限公司 基于amf为荧光素标记物的双酚a荧光偏振免疫分析检测方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4962035A (en) * 1987-12-01 1990-10-09 President And Fellows Of Harvard College DNA encoding IgE receptor alpha-subunit or fragment thereof

Also Published As

Publication number Publication date
AU652024B2 (en) 1994-08-11
IL100869A0 (en) 1992-11-15
EP0499112A1 (en) 1992-08-19
IE920434A1 (en) 1992-08-12
FI920565A7 (fi) 1992-08-12
UY23374A1 (es) 1992-07-30
NZ241552A (en) 1994-03-25
FI920565L (fi) 1992-08-12
AR245784A1 (es) 1994-02-28
YU13392A (sh) 1995-01-31
HUT63205A (en) 1993-07-28
RO109707B1 (ro) 1995-05-30
NO920523L (no) 1992-08-12
FI920565A0 (fi) 1992-02-11
KR920016105A (ko) 1992-09-24
BR9200442A (pt) 1992-10-20
AU1080292A (en) 1992-08-13
MX9200526A (es) 1992-08-01
NO920523D0 (no) 1992-02-10
JPH05252988A (ja) 1993-10-05
HU9200293D0 (en) 1992-04-28
CA2059842A1 (en) 1992-08-12
CS39092A3 (en) 1992-09-16
ZA92800B (en) 1992-10-28

Similar Documents

Publication Publication Date Title
IS3718A7 (is) Amínóbenzodiazepines og aðferð til framleiðslu þess
NO306419B1 (no) Anordning og framgangsmaate for isolering av produksjonssone
FI981765L (fi) Sytokiinin vastainen vasta-aine ja menetelmä sen valmistamiseksi
DK0511011T3 (da) Nye antistoffer og fremgangsmåde til anvendelse heraf
DK0445382T3 (da) Trykføler og fremgangsmåde til fremstilling heraf
IS3813A (is) Mótefni gegn viðtökum fyrir IgE og aðferð til framleiðslu þess
KR890005857A (ko) 범프 및 그 형성방법
IS3865A (is) Hliðstæð aðferð til framleiðslu á benzofuran afleiðum og milliefni til notkunar við aðferðina
KR860005944A (ko) 구조물 성분들에 압축응력을 가하는 중간 앵커(anchoy) 장치 및 그 설치 방법
NO177472C (no) Fremgangsmåte og anordning for å korrelere to inngangssignaler
DK296988A (da) Fremgangsmaade og anlaeg til kontinuerlig hydrolysering af keratinholdigt materiale
IS3603A7 (is) Brennslukol og aðferð til framleiðslu þeirra
IS3857A (is) Karboxýl-sýruafleiður og aðferð til framleiðslu þeirra
DK223089A (da) Lysdaemper og fremgangsmaade til fremstilling deraf
PT87630A (pt) Hydraulic cement and process for its production
DK154888D0 (da) Kompakt lysstofroer og fremgangsmaade til fremstilling heraf
NO881369D0 (no) Fremgangsmaate og apparat for omdannelse av metan til hoeyere hydrokarboner.
DK565981A (da) Kommutator og fremgangsmaade til fremstilling deraf
DK96394A (da) 5-Halogenalkylidinimono-1-arylpyrazoler og fremgangsmåde til fremstilling deraf
DK20391A (da) Honningpulver og fremgangsmaade til fremstilling deraf
DK306189D0 (da) Immobiliseret lipasepraeparat og anvendelse deraf til estersyntese
IT1238530B (it) Elemento di fissaggio e metodo per la sua produzione
IS3344A7 (is) Efni afleidd af pyrimidine og aðferð til framleiðslu þeirra
DK3191D0 (da) Flydende line og fremgangsmaade til fremstilling deraf
DK509882A (da) Konstruktionselement og fremgangsmaade til fremstilling af samme